Chinook Therapeutics, Inc. Stock
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
Latest transcript on Chinook Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Noopur Liffick
IRC | Investor Relations Contact | - | 20-09-30 |
Valerie Fauvelle
LAW | General Counsel | - | - |
Sukhi Thethy
AUD | Comptroller/Controller/Auditor | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.03% | 237 M€ | +1.33% | - |
1st Jan change | Capi. | |
---|---|---|
-0.49% | 105B | |
+3.31% | 97.5B | |
+1.66% | 22.19B | |
-16.16% | 21.33B | |
-6.82% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |